Hurdles for PSE purchases in Louisiana bill
This article was originally published in The Tan Sheet
Executive Summary
Buying ephedrine- or pseudoephedrine-containing products in the state becomes more difficult under legislation introduced April 3 by Rep. Fred Mills, a Democrat from the Parks, La., area. House Bill 177 would require pharmacists to ask for photo ID and record the purchase of any methamphetamine precursor for entry into the pharmacy's dispensing information system. Given the "devastating effect" of meth on people in Louisiana, the bill says a pharmacist is best qualified to weigh the benefits of dispensing a precursor product against the risk of illegal use. The Missouri Senate recently rejected a measure that would have made cough/cold products with ephedrine or PSE available by prescription only (1"The Tan Sheet" March 16, 2009, In Brief)
You may also be interested in...
Kan. Senate votes for meth precursor e-tracking
A statewide system for tracking purchases of nonprescription products containing ephedrine or pseudoephedrine is a step closer to reality after the Kansas Senate passes S.B. 248. Following its March 12 approval by 37-3 margin, the bill will next be considered in the state House. Other states have set up similar electronic logbooks to monitor purchases of methamphetamine precursors - including Tennessee, which says its statewide tracking system has been a success (1"The Tan Sheet" Feb. 2, 2009, p. 4). ... Mo. Senate votes down PSE Rx amendment: An attempt to amend a larger crime bill with a measure requiring a prescription for products containing methamphetamine precursors fails in the Missouri state Senate March 4. The amendment offered by state Sen. Jason Crowell, a Republican representing the Cape Girardeau area, "was soundly defeated" by voice vote, according to a legislature spokesman. Separately, Crowell has sponsored a bill, S.B. 160, to make cough/cold remedies containing ephedrine or pseudoephedrine available by prescription only, which remains viable (2"The Tan Sheet" Feb. 23, 2009, p. 3). A companion bill, H.B. 496, is under consideration in the House and has been passed out of committee
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.